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The translocation of mRNA and tRNA through the
ribosome is catalyzed by elongation factor G
(EF-G), a universally conserved guanosine triphos-
phate hydrolase (GTPase). The mechanism by which
the closely related decapeptide antibiotics dityromy-
cin and GE82832 inhibit EF-G-catalyzed transloca-
tion is elucidated in this study. Using crystallographic
and biochemical experiments, we demonstrate that
these antibiotics bind to ribosomal protein S12 in
solution alone as well as within the small ribosomal
subunit, inducing long-range effects on the ribo-
somal head. The crystal structure of the antibiotic
in complex with the 70S ribosome reveals that the
binding involves conserved amino acid residues of
S12whosemutations result in in vitro and in vivo anti-
biotic resistance and loss of antibiotic binding. The
data also suggest that GE82832/dityromycin inhibits
EF-G-catalyzed translocation by disrupting a critical
contact between EF-G and S12 that is required to
stabilize the posttranslocational conformation of
EF-G, thereby preventing the ribosome-EF-G com-
plex from entering a conformation productive for
translocation.INTRODUCTION
The movement of tRNA through the ribosome is catalyzed in
bacteria by elongation factor G (EF-G), a universally conserved
guanosine triphosphate hydrolase (GTPase) that accelerates
the translocation of tRNA from the ribosomal A-site to the
P-site (Katunin et al., 2002; Rodnina et al., 1997). Although spon-
taneous translocation occurs, its rate in the absence of EF-G is
orders of magnitude slower—too slow to meet the needs of a
living cell (Asatryan and Spirin, 1975; Katunin et al., 2002; PeskeCet al., 2000; Southworth et al., 2002). Several small-molecule in-
hibitors of translocation have been identified (Peske et al., 2004;
Walter et al., 2012), providing insight into the workings of EF-G
and trapping EF-G-bound conformations of the ribosome for
use in structural studies (Gao et al., 2009; Munro et al., 2010;
Ogle et al., 2002; Stark et al., 2000). In addition, inhibitors of
translocation can be used as antibiotics, provided they do not
also interfere with protein synthesis in higher organisms (Stanley
et al., 2010).
Dityromycin is a cyclic decapeptide antibiotic containing
several modified amino acids. It was originally discovered in
the 1970s (Omura et al., 1977) and structurally characterized a
decade later (Teshima et al., 1988; Figure 1A). The closely related
antibiotic GE82832 was identified as a translation inhibitor by
high-throughput screening of a library of natural products
(Brandi et al., 2006, 2012). Despite the fact that GE82832 and
dityromycin are secondary metabolites of different micro-organ-
isms, recent studies have shown that both antibiotics target the
30S ribosomal subunit, inhibit translocation, and display the
same microbiological and functional properties; in addition, their
chemical structures are identical, except for a difference of two
mass units (Brandi et al., 2012).
Biochemical studies have shown that GE82832/dityromycin
blocks the EF-G-catalyzed movement of peptidyl-tRNA and
mRNA from the ribosomal A-site to the P-site without preventing
the ribosomal binding of the elongation factor, which remains
able to stimulate guanosine triphosphate (GTP) hydrolysis on
the ribosome and to dissociate the cleaved gPi, albeit at a some-
what slower rate than in the absence of GE82832/dityromycin
(Brandi et al., 2006, 2012).
Whereas GE82832/dityromycin arrests the translocation of
tRNA through the ribosome, the compound has almost no effect
on the accommodation of tRNA into either the P- or A-site, either
in the context of the 30S subunit or the full 70S ribosome (Brandi
et al., 2006). Additional experiments showed that preincubation
of 30S subunits with GE82832/dityromycin inactivates protein
synthesis whereas the same treatment of 50S subunits has
little effect, thereby suggesting that GE82832/dityromycin
interacts almost exclusively with the 30S subunit. Furthermore,ell Reports 6, 357–365, January 30, 2014 ª2014 The Authors 357
Figure 1. Structure of Dityromycin and
Comparison with GE82832
(A) Minimally biased Fo-Fc difference Fourier
electron density map contoured at 3s for dityr-
omycin in complex with the bacterial ribosome
from T. thermophilus.
(B) Minimally biased Fo-Fc difference Fourier
electron densitymap contoured at 3s for GE82832
in complex with the bacterial ribosome from
T. thermophilus.
(C) Model of dityromycin (tan with oxygen colored
red and nitrogen blue) docked into the same dif-
ference Fourier map shown in (A).
(D) Chemical structure of dityromycin, a secondary
metabolite produced by Streptomyces strain
AM-2504. GE82832 is a secondary metabolite
produced by Streptosporangium cinnabarinum
(strain GE82832) whose structure is nearly iden-
tical to that of dityromycin but for a two-dalton
mass difference likely resulting from an additional
point of unsaturation.experiments of chemical and hydroxyl radical cleavage protec-
tion of 16S rRNA suggest that GE82832/dityromycin modulates
the reactivity/accessibility of nucleotides located in the head of
the small subunit, raising the possibility that the compound may
alter the conformational dynamics of the ribosome (Brandi
et al., 2006, 2012). However, despite these data and the sugges-
tion that GE82832/dityromycin might interfere with intersubunit
rotation and ratcheting (Brandi et al., 2006), the exactmechanism
whereby this antibiotic inhibits translocation remains unknown.
Thus, to better understand the mechanism of action of
GE82832/dityromycin, we determined the structure of its com-
plex with the bacterial ribosome from Thermus thermophilus.
We find that GE82832/dityromycin interacts with a region of
the ribosome that has not been previously identified as an antibi-
otic-binding site (Wilson, 2009) but has been shown to be func-
tionally important in controlling the translocation of tRNA through
the ribosome (Cukras et al., 2003; McMahon and Landau, 1982;
Vila-Sanjurjo et al., 2007). On the basis of this observation, we
suggest that the antibiotic acts through a unique mechanism
and further outline a region of the ribosome that can be the target
of future structure-based antibiotic design efforts.
RESULTS
After demonstrating that GE82832 is active in inhibiting transla-
tion in a T. thermophilus system at both 50C and 70C358 Cell Reports 6, 357–365, January 30, 2014 ª2014 The Authors(Figure S1), the crystal structures of
GE82832 and dityromycin in complex
with the bacterial ribosome from
T. thermophilus were determined, and
statistics for the data are shown in
Table 1. The structures were solved by
molecular replacement using an existing
model of the 70S ribosome (Polikanov
et al., 2012) in which P-site tRNA and
mRNA were bound but no other ligandswere present. Coordinates for the antibiotics were withheld dur-
ing refinement in PHENIX (Adams et al., 2010), and minimally
biased Fobs-Fcalc difference Fourier electron density maps were
used to localize the antibiotics with respect to the ribosome.
An atomic model of dityromycin was generated from the chem-
ical structure of the antibiotic (Teshima et al., 1988) using the
PRODRG server (Schu¨ttelkopf and van Aalten, 2004), and re-
straints based on the idealized three-dimensional geometry of
dityromycin were used to refine dityromycin into our electron
density maps. The final model for dityromycin along with differ-
ence Fourier maps for GE82832 and dityromycin are shown in
Figure 1.
GE82832/Dityromycin Interacts with Ribosomal
Protein S12
GE82832/dityromycin binds to the shoulder of the 30S subunit
and interacts exclusively with ribosomal protein S12 on the small
subunit (Figures 2A and 2B). No direct interaction between dityr-
omycin and the ribosomal RNA is observed; the antibiotic is 5.5 A˚
away from the phosphate of residue G361 and 7 A˚ away from the
phosphate of G362 (16S rRNA; E. coli numbering). On the ribo-
some, GE82832/dityromycin contacts histidine 76 of S12, prob-
ably forming a hydrogen bond between the delta nitrogen of
His76 and the hydroxyl group of the epoxy hydroxy dehydroiso-
leucine residue of GE82832/dityromycin (Figures 2C and 2D).
The phenyl glycine residue of GE82832/dityromycin also
Table 1. Data Collection and Refinement Statistics
Crystal
70S-tRNA-
Dityromycin
70S-tRNA-
GE82832
Diffraction Data
Space group P212121 P212121
Unit cell dimensions, A˚
(a 3 b 3 c)
210.08 3
449.83 3 619.65
209.68 3
450.64 3 622.54
Wavelength, A˚ 1.100 1.100
Resolution range
(outer shell), A˚
49.7–3.00
(3.08–3.00)
49.7–3.10
(3.18–3.10)
I/sI (outer shell
with I/sI = 1)
6.19 (1.00) 5.19 (0.96)
Resolution at which
I/sI = 2, A˚
3.27 3.45
Wilson B-factor, A˚2 66.79 70.99
Completeness
(outer shell), %
98.8 (99.1) 98.2 (99.2)
Rmerge, % 19.9 (140.4) 20.5 (121.9)
CC(1/2) at which
I/sI = 1, %
24.0 27.5
Number of
crystals used
1 1
Number of
reflections used:
Observed 3,948,062 3,118,277
Unique 1,143,138 1,034,964
Redundancy 3.45 3.01
Refinement
Rwork/Rfree, % 20.3/25.9 20.3/25.9
Number of Nonhydrogen Atoms
RNA 190,374 190,375
Protein 91,181 91,173
Ions (Mg, Zn, Fe) 2,003 2,003
Waters 2,520 2,520
Ramachandran Plot
Favored regions, % 93.43 92.25
Allowed regions, % 5.65 6.54
Outliers, % 0.92 1.21
Deviations from Ideal Values (rmsd)
Bond, A˚ 0.010 0.009
Angle, degrees 1.515 1.466
Chirality 0.062 0.060
Planarity 0.007 0.007
Dihedral, degrees 17.113 16.907
Average B-factor (overall), A˚2 62.3 62.6
Rmerge = S jI – < I > j / S I, where I is the observed intensity, and < I > is the
average intensity from multiple measurements. Rwork = SjFobs – Fcalcj / S
Fobs. For recalculation of Rfree, 5%of the truncated data set was excluded
from the refinement. rmsd, root-mean-square deviation.appears to stack against the aromatic surface of His76, further
stabilizing this contact. The second major contact is formed by
the cyclic dityrosine moiety of GE82832/dityromycin, which
stacks against the guanidinium group of arginine 30 and is sup-
ported by hydrophobic interactions with the side chains of valine
32 and valine 78 of S12 (Figure 2E). The N,N-dimethyl valine res-Cidue of GE82832/dityromycin also comeswithin 3.5 A˚ of Arg55 of
S12 (Figure 2D). The interaction of the antibiotic with His76 and
Val78 is confirmed by the finding that E. coli ribosomes bearing
mutations of residues His76 (R, G, or K) or Val78D of protein
S12 are resistant to inhibition of in vitro mRNA translation by
GE82832 (Figure 3A). Furthermore, the same mutations confer
in vivo resistance to GE82832, whereas both wild-type E. coli
MRE600 as well as a standard laboratory strain, MC4100, which
carries an S12 substitution (K42R) conferring streptomycin resis-
tance (Casadaban, 1976; see Experimental Procedures), are
sensitive to the antibiotic (Figure 3B, middle plate). However,
the same S12 GE82832-resistant mutants display a strepto-
mycin-sensitive phenotype, unlike E. coli MC4100 (Figure 3B,
lower plate).
It has long been known that decoding fidelity is influenced by
ribosomal protein S12 (Gorini, 1971; Strigini and Brickman,
1973); thus, the evidence that GE82832/dityromycin binds to
this protein prompted us to investigate a possible effect of this
antibiotic on the accuracy of mRNA translation. To do so, the
level of translationmeasured from the incorporation of a radioac-
tive precursor in the acid-insoluble product was compared to the
level of correctly synthesized protein, as immunologically quan-
tified by ELISA (Fabbretti et al., 2012). By contrast to what occurs
in the presence of streptomycin, both tests show the same
extent of inhibition in the presence of GE82832/dityromycin, indi-
cating that this antibiotic does not induce codon misreading
(Figure S2).
The interactions observed between GE82832/dityromycin and
S12 suggest that the thermodynamic stability of the protein-drug
complex could be quite high. In light of this, the possibility that
the antibiotic might establish an interaction with the isolated ri-
bosomal protein was also investigated. The results obtained in
this experiment clearly show that, unlike two control proteins
(serum albumin and initiation factor IF3), GE82832/dityromycin
copurifies with protein S12, indicating that this isolated ribo-
somal protein can indeed establish a stable interaction with the
antibiotic (Figure 3C).
Previous chemical (Brandi et al., 2006) and hydroxyl radical
(Brandi et al., 2012) probing experiments had shown that
GE82832/dityromycin affects the accessibility of 16S rRNA ba-
ses located in the head of the 30S subunit, near protein S13,
but no effect was detected near S12. Whereas the latter result
would be fully compatible with the crystallographic data showing
the lack of contacts between the antibiotic and 16S rRNA, whose
closest phosphate group is >5 A˚ away (see above), the altered
RNA accessibility near S13 deserved renewed attention, also
in light of the role played by this protein and by the 30S head rota-
tion in translocation (Cukras et al., 2003; Pulk and Cate, 2013;
Tourigny et al., 2013; Zhou et al., 2013). Therefore, a possible
role of protein S13 in the mechanism of translation inhibition by
this antibiotic was investigated using ribosomes from cells
bearing an rpsM (the gene encoding S13)-null mutation (Cukras
and Green, 2005). However, the in vitro mRNA translation test
carried out with these ribosomes demonstrates that the lack of
S13 does not alter their sensitivity to GE82832/dityromycin inhi-
bition (Figure 3A, blue tracing).
Finally, in situ probing of the rRNA was analyzed (Figures 4A
and 4B) by comparing the effects of GE82832/dityromycin onell Reports 6, 357–365, January 30, 2014 ª2014 The Authors 359
Figure 2. Binding Site of GE82832/Dityromycin with the Ribosome and Their Interactions with S12
(A) Overview of the 70S ribosome (50S, light blue; 30S, yellow) in complex with dityromycin (red highlight) with S12 (blue) shown.
(B) Another view of the binding site of GE82832/dityromycin in which the large subunit has been removed for clarity.
(C) Close up of dityromycin (tan, red highlight) bound to S12 (white, blue highlight).
(D) Another view of dityromycin (tan) interacting with S12 (white), highlighting the interaction between His76 of S12 and the phenyl glycine and epoxy hydroxy
dehydroisoleucine residues of dityromycin. Arg55 packs against the N,N-dimethyl valine of dityromycin, and Thr34 comeswithin 4 A˚ of the phenyl glycine residue.
(E) The dityrosine moiety of dityromycin stacks with Arg30 and rests on a hydrophobic surface formed by Val32 and Val78.
(F) Chemical structure of dityromycin, indicating the regions of the antibiotic highlighted in (D) and (E).the accessibility of 16S rRNA to hydroxyl radical cleavage in
wild-type (WT) 30S subunits with its accessibility in mutated
30S subunits containing an H76 substitution that made them
GE82832/dityromycin-resistant. As seen in Figure 4A, the altered
accessibility to hydroxyl radical cleavage of 16S rRNA bases in
the 30S subunit head near S13 was fully confirmed in WT 30S
subunits, with a clear enhancement of exposure for bases
A1329–U1330, A1332–A1339, C1344, and C1359 and a slight
protection of G1331; however, no comparable effects could be
detected in the 30S subunits bearing the S12 H76 mutation.
Remarkably, all the bases whose accessibilities are affected by
the antibiotic are very far from S12 (Figure 4C). Concerning the
S12- proximal region of the 30S subunit, it can be seen that
the antibiotic has no effect on the accessibility of bases in this re-
gion, aside from a slight increased exposure of bases 362 and
363 (Figure 4B).
Taken together, these findings could be explained either by
the existence of multiple antibiotic-binding sites on the 30S sub-
unit and/or by long-range conformational changes of the subunit360 Cell Reports 6, 357–365, January 30, 2014 ª2014 The Authorsinduced by GE82832/dityromycin binding. However, the crystal-
lographic data are consistent with a single ribosomal binding site
for the antibiotic; furthermore, although our ‘‘pull-down’’ experi-
ments do not allow us to rule out the existence of additional, low-
affinity antibiotic-binding site(s) (Figure 4D), the nature of most of
the effects (increased exposure) observed near S13 in WT 30S
and the fact that no alterations of the cleavage patterns are
seen with the 30S subunit bearing the H76 mutation in S12
give a clear indication that GE82832 causes a long-range confor-
mational change in the head of the subunit. The fact that no
conformational rearrangements resulting from GE82832/dityro-
mycin binding were detectable in the crystal structure can be
explained by the fact that the crystal packing has probably sta-
bilized a single conformation of the subunit.
DISCUSSION
Protein S12 plays a critical role in bacterial translation (Cukras
et al., 2003; Gregory et al., 2009; McMahon and Landau, 1982;
Figure 3. Involvement of Ribosomal Protein
S12 in GE82832/Dityromycin Binding
(A) Effect of S12 mutations on the in vitro
ribosome susceptibility to GE82832/ dityromycin.
027IF2Cp(A) mRNA translation was tested in the
presence of the concentrations of GE82832 indi-
cated in abscissa in an E. coli MRE600 trans-
lational system reconstituted with postribosomal
supernatant and purified WT ribosomes (black
circle) or ribosomes lacking ribosomal protein S13
(blue square) or carrying the following amino acid
substitutions in S12: H76R (orange inverted trian-
gle); H76G (red triangle); H76K (green square);
V78D (light blue diamond). The % inhibition re-
ported in the ordinate was calculated by com-
parison with mRNA translation in the absence of
antibiotic.
(B) Effect of S12 mutations on the in vivo sus-
ceptibility to GE82832 and streptomycin; Wild-
type E. coli MRE600, E. coli MC4100 (carrying a
K42R substitution in S12 conferring streptomycin
resistance), and E. coli MC41 carrying H76R, H76
G, H76K, and Val78Dmutations in S12were plated
as indicated in each case on Luria Bertani-agar
plates containing no antibiotics (upper plate),
500 mg/ml GE82832 (middle plate), or 100 mg/ml
streptomycin (lower plate).
(C) Binding of GE82832 to isolated S12. 7 mM of
GE82832 were incubated for 10 min at 20C in
100 ml of buffer (10 mM Tris-HCl [pH 7.1]; 10 mM
Mg acetate; 60 mM NH4Cl; 1 mM dithiothreitol)
without further additions (orange square) or con-
taining 20 mM of purified ribosomal protein S12
(red triangle), 20 mM of initiation factor IF3 (blue
open square), or 20 mM of bovine serum albumin
(green open triangle). The samples were then
loaded on an Amicon spin filter (MWCO 3 KDa).
After 10 min of centrifugation at 12,000 rpm, the
eluate was collected and increasing aliquots
tested for their capacity to inhibit 027IF2Cp(A)
mRNA translation in a standard E. coli-based
system. A sample of noncentrifuged antibiotic was
also tested as a control (black circle).Sharma et al., 2007; Vila-Sanjurjo et al., 2007; Yates, 1979; Zen-
gel et al., 1977). Protein S12 is positioned on the shoulder of the
30S subunit, where it reaches into the decoding center and acts
as a control element in tRNA selection (Yates, 1979) and the
translocation of tRNA-mRNA through the ribosome (Cukras
et al., 2003). S12 has also been shown to influence the inhibition
of translation by several antibiotics, including streptomycin (Vila-
Sanjurjo et al., 2007) and paromomycin (Sharma et al., 2007). The
structural and biochemical data presented here show that S12 is
the target of GE82832/dityromycin inhibition through an interac-
tion that is distinct from that of any other ribosomal inhibitor and
also pivotal in a GE82832/dityromycin-mediated conformational
change of the head of the 30S subunit thatmight be related to the
mechanism of translation inhibition.
The long-distance S12-mediated effects of GE82832 on the
accessibility of 16S rRNA bases of the 30S subunit head underlie
the well-established dynamics of this region of the subunit (Pulk
and Cate, 2013; Tourigny et al., 2013; Wang et al., 2012; Zhou
et al., 2013) as well as the ability of protein S12 to act as a confor-Cmational relay for the subunit (Gregory et al., 2009; Vila-Sanjurjo
et al., 2007; Zengel et al., 1977) and the functional interrelation-
ship between S12 and S13 (Cukras et al., 2003). However, it is
not possible to conclude whether these effects, which do not
occur in the GE82832-resistant 30S subunits, have any causal
relationship with the mechanism of translocation inhibition.
EF-G-catalyzed translocation has been shown to involve a
number of conformational rearrangements of EF-G, the ribo-
some, and ribosome-bound tRNA-mRNA (Ermolenko andNoller,
2011; Frank et al., 2007; Munro et al., 2010; Peske et al., 2000,
2004; Ratje et al., 2010; Savelsbergh et al., 2003). In addition
to biochemical evidence indicating that interactions between
S12 and EF-G control translocation (Cukras et al., 2003), crystal
structures of EF-G bound to the ribosome in posttranslocational
and ratcheted pretranslocational conformations show that EF-G
interacts extensively with S12 (Feng et al., 2013; Gao et al., 2009;
Pulk and Cate, 2013; Tourigny et al., 2013; Zhou et al., 2013).
Critically, domain 3 of EF-G binds to S12 in the region of
His 76 (E. coli), and comparison of the ribosome bound toell Reports 6, 357–365, January 30, 2014 ª2014 The Authors 361
Figure 4. Long-Distance Effects of GE82832
on the InSitu16S rRNACleavagebyHydroxyl
Radicals
(A and B) Primer extension analysis of the in situ
cleavage pattern of 16S rRNA (A) in the 1340 re-
gion (near S13) in WT 30S (left lanes) and S12
H76K mutant 30S ribosomal subunits (right lanes)
and (B) in the 360 region (near S12) in WT 30S
subunits in the absence (0) and in the presence of
3.8, 38, and 77 mM GE82832, as indicated above
each lane. The lanes marked G and A are
sequencing gels.
(C) Image of the 30S ribosomal subunit in which
the bases whose accessibility to cleavage is
increased (purple) or decreased (green) by
GE82832 are highlighted; the position of protein
S12 (light blue) and of GE82832/dityromycin-
binding site (light red) are also indicated.
(D) Lack of GE82832 binding by ribosomes car-
rying His76 and Val78 substitutions. The extent
(%) of inhibition of mRNA translation by eluates of
Amicon spin filter (MWCO 50 KDa) on which 3 mM
(red bars) or 9 mM (black bars) of GE82832 were
loaded alone or together with 30 mM of WT 30S,
50S, and 70S particles or 70S ribosomes carrying
H76K, H76G, H76R, and V78D substitutions in
S12, as indicated under each histogram bar. The
other experimental details are described in the
legend of Figure 3.EF-G versus GE82832/dityromycin shows that both molecules
interact with a similar region of S12 (Figure 5). Thus, our structure
indicates that the binding of GE82832/dityromycin sterically oc-
cludes EF-G from entering a posttranslocational conformation
on the ribosome by blocking the interaction between domain 3
of EF-G and protein S12 on the small ribosomal subunit.
Although our crystal structure indicates that GE82832/dityro-
mycin blocks the binding of EF-G in the pretranslocational
conformation, EF-G can still catalyze the hydrolysis of GTP on
the ribosome, though the kinetics of phosphate release are
altered (Brandi et al., 2012). Because GTP hydrolysis and phos-
phate release occur in steps separate from the engagement of
domain 4 of EF-G with the A-site (Munro et al., 2010), the possi-
bility that GTP hydrolysis and translocation are decoupled by
GE82832/dityromycin is not unreasonable; viomycin and specti-
nomycin also inhibit translocation but do not block GTP hydroly-
sis (Pan et al., 2007), whereas mutations in EF-G have also been
shown to decouple translocation and GTP hydrolysis (Savels-
bergh et al., 2000).
Both biochemical and structural experiments have estab-
lished that S12 plays a critical role in translocation (Cukras
et al., 2003; Gao et al., 2009; Pulk and Cate, 2013; Tourigny
et al., 2013; Zhou et al., 2013). Entering the posttranslocational362 Cell Reports 6, 357–365, January 30, 2014 ª2014 The Authorsstate in the presence of EF-G requires
that domain 3 of EF-G engages S12.
S12 also acts as a control element in
translocation; removal of S12 along with
proteins S11 or S13 stimulates factor-
independent translocation, whereas
removal of S12 and S5, S7, S8, or S14blocks factor-catalyzed translocation (Cukras et al., 2003). Inter-
estingly, removal of protein S13 does not reduce the sensitivity of
E. coli ribosomes to GE82832/dityromycin (Figure 3A). Overall,
the results indicate that GE82832/dityromycin may inhibit trans-
lation by preventing the complex between EF-G and the ribo-
some from adopting a conformation that is productive for trans-
location. This premise is consistent with the finding that even an
excess of EF-G does not relieve the inhibition (Figure S3), a result
which is consistent with GE82832/dityromycin affecting the
position of EF-G on the ribosome and not its binding.
Although the structure of GE82832/dityromycin in complex
with the bacterial ribosome explains its activity as a translocation
inhibitor, our structure would also be consistent with GE82832/
dityromycin affecting the ability of EF-Tu to deliver aminoacyl-
tRNA to the ribosomal A-site. The mutation of several residues
of protein S12 that are distant from the decoding center have
been shown to increase miscoding errors; two of these, Thr57
and Val78 (E. coli; Agarwal et al., 2011), form part of the binding
pocket for GE82832/dityromycin. In addition, His76 (E. coli), the
same residue that we show to be critical for GE82832/dityromy-
cin binding (Figures 3 and 4), is involved in signaling EF-Tu
when codon recognition has taken place (Gregory et al., 2009).
However, only at high concentrations (10 mM) does
Figure 5. Dityromycin Blocks the Transition from Pre- to Post-
translocational Conformations of EF-G
(A) The left panel shows a cross-section of the ribosome (30S yellow; 50S light
blue) with dityromycin (red) and S12 (blue) highlighted. The right panel shows
the same view but with EF-G (green) bound in the posttranslocational
conformation (Gao et al., 2009); PDB ID code 2WRI.
(B) Close-up view of the clash between dityromycin and EF-G bound in the
posttranslocational conformation.
(C) Scheme of translocation and its inhibition by dityromycin/GE82832. The
50S (light blue) and 30S (yellow) subunits, deacylated tRNA (light brown),
peptidyl tRNA (light gray), and S12 (blue) are shown along with EF-G (green
with domains I–V indicated) and dityromycin (red).GE82832/dityromycin inhibit (50%) the delivery of tRNA to the
A-site in the absence of EF-Tu, whereas at the same concentra-
tion, it has virtually no effect when EF-Tu is present (Brandi et al.,
2006). This is probably due to the fact that aminoacyl-tRNA and
EF-Tu outcompete the antibiotic from its binding site, and it
should be noted that overall protein synthesis and translocation
are inhibited at the same rate by GE82832/dityromycin (Brandi
et al., 2006).
Unlike EF-G, the affinity of the ternary complex of EF-Tu
with tRNA and GTP for the ribosome depends heavily on the
interaction between the anticodon of the EF-Tu-bound tRNA
and the codon of the mRNA: the correct pairing of tRNA
and mRNA in the decoding center can increase the affinityCof the ternary complex for the ribosome by as much as
1,000-fold as compared to a single mismatch (Gromadski
and Rodnina, 2004; Pape et al., 1999; Thompson et al.,
1986), and the equilibrium dissociation constant of the correct
EF-Tu/tRNA/GTP ternary complex for the ribosome is on the
order of 1 nM (Harrington et al., 1993; Louie and Jurnak,
1985). In contrast, the binding of domain IV of EF-G in the de-
coding center does not appear to be as critical to the overall
affinity of the factor for the ribosome, as evidenced by the fact
that a conformationally restricted EF-G that is unable to trans-
locate tRNA (and therefore likely does not bind with domain IV
in the A-site) has only a slightly reduced affinity for the ribo-
some and remains capable of catalyzing GTP hydrolysis on
the ribosome (Peske et al., 2000). Therefore, we speculate
that the affinity of the EF-Tu/tRNA/GTP ternary complex for
the decoding center is sufficient to outcompete GE82832/
dityromycin bound to the ribosome. Given that the minimum
inhibitory concentration for GE82832/dityromycin is only in
the low mM, it is possible that an antibiotic that bound to
the same region of the ribosome with increased affinity would
be capable of inhibiting the delivery of aminoacyl-tRNA by
EF-Tu.
The binding site of GE82832/dityromycin also overlaps with
that of ribosome recycling factor (RRF) (Gao et al., 2007).
Because RRF and EF-G work together in recycling, it is unclear
whether the effects of GE82832/dityromycin on RRF could be
disentangled from its effects on EF-G alone, but a superposition
of RRF bound to both the E. coli and T. thermophilus ribosomes
shows that RRF and GE82832/dityromycin share a contact point
with S12 (Borovinskaya et al., 2007; Weixlbaumer et al., 2007;
Yokoyama et al., 2012). Superposition with the ratcheted
E. coli ribosome bound to RRF shows that GE82832/dityromycin
would sterically clash with domain 2 of RRF, whereas only a
slight clash would exist between GE82832/dityromycin and
RRF bound to a classical-state ribosome (Figure S4).
Although questions remain regarding the impact of GE82832/
dityromycin on RRF, EF-Tu, and the accommodation of tRNA,
our structure provides a clear mechanism for how this antibiotic
is able to inhibit the EF-G-catalyzed translocation of tRNA.When
bound in the posttranslocational conformation, domain 3 of EF-G
makes extensive contacts with S12 in the region of His 76 (E. coli;
Gao et al., 2009; Pulk and Cate, 2013; Tourigny et al., 2013; Zhou
et al., 2013). A comparison of S12 bound to EF-G versus
GE82832/dityromycin shows that both molecules engage a
similar region of S12 and that both cannot simultaneously bind
S12 (Figure 5). Therefore, the binding of GE82832/dityromycin
sterically occludes EF-G from entering a posttranslocational
conformation on the ribosome.EXPERIMENTAL PROCEDURES
GE82832 was originally identified, isolated, and purified from Streptosporan-
gium cinnabarinum strain GE82832 at Biosearch Italia within the European
Commission project ‘‘Ribosome Inhibitors’’ (contract QLRT-2001-00892EC).
Dityromycin, purified from Streptomyces sp. strain AM-2504 was a kind gift
of Prof. O. Omura. 70S ribosomes from T. thermophiluswere purified and crys-
tallized according to previously published protocols (Bulkley et al., 2010). Prior
to crystallization, dityromycin or GE82832 was added at a concentration of
100 mM and incubated at 37C for 5 min. Fifteen micromolar mRNA withell Reports 6, 357–365, January 30, 2014 ª2014 The Authors 363
sequence GGCAAGGAGGUAAAAAUGUUC was then added and further incu-
bated for 5 min at 37C, after which fMet-tRNAfMet was added at a concentra-
tion of 8 mM, and ribosomes were further incubated for 5 min at 37C.
Ribosomes were then diluted to a final concentration of 5 mM in buffer
composed of 5 mM HEPES (pH 7.5), 50 mM KCl, 10 mM NH4Cl, and 10 mM
MgAc2 and then equilibrated via sitting-drop vapor diffusion against a reservoir
solution made up of 2.9% (w/v) polyethylene glycol 20K, 9% (v/v) 2-methyl-
2,4-pentanediol, 175 mM L-arginine, and 100 mM Tris-HCl (pH 7.6). Immedi-
ately prior to equilibration, 3 to 4 ml of reservoir solution were added to 3 ml
of ribosome-containing solution.
Crystals appeared after approximately 4 days and were harvested after
8 days. Following stabilization by gradually increasing the concentration of
2-methyl-2,4-pentanediol to 40% (v/v), crystals were equilibrated for 12 hr
and flash frozen in a nitrogen cryostream at 80 K. Diffraction data were
collected at the National Synchrotron Light Source on beamline X-25 using a
Pilatus 6M detector. Data reduction was performed with the program XDS
(Kabsch, 2010), and an initial solution was generated by molecular replace-
ment with PHASER (McCoy et al., 2007) using the T. thermophilus 70S ribo-
some, from which all ligands were removed as a search model (Polikanov
et al., 2012). The solution was then refined with the PHENIX package (Adams
et al., 2010).
Themodel for dityromycin was generated using the PRODGR server (Schu¨t-
telkopf and van Aalten, 2004) based on the chemical structure of dityromycin
(Teshima et al., 1988). Restraints from PRODRG were originally used, but
modified restraints with idealized geometry were generated and used for the
final refinement. The antibiotic model was placed into Fo-Fc difference Fourier
maps using ribosomemodels that had been refined in the absence of antibiotic
coordinates. Final coordinates for the antibiotic ribosome complexes are
deposited in the Protein Data Bank (PDB) and the accession numbers are
listed below.
In vitro translation and miscoding tests were carried out in E. coli or
T. thermophilus systems programmed with 027IF2Cp(A) mRNA as described
(Brandi et al., 2007; Fabbretti et al., 2012). In situ probing the 16S rRNA by hy-
droxyl radical cleavage was carried out as described (Fabbretti et al., 2007).
E. coli strains carrying mutations in S12 were constructed by recombineer-
ing, as previously described (Agarwal et al., 2011). Briefly, chromosomal DNA
from a strain carrying a chloramphenicol acetyl transferase (cat) cassette inte-
grated upstream of the rpsL gene was used as a template in a two-step, exten-
sion overlap PCR, with oligonucleotides randomized at codon positions 76 or
78. The amplified fragments carrying the mutated rpsL gene and cat cassette
were electroporated into MC323 (Agarwal et al., 2011), selecting for chloram-
phenicol resistance. The rpsL mutations were identified by sequencing, and
the desired alleles were then transferred into strain MC41 (F D(lac-pro)
thi). The cat cassette was removed by transient expression of plasmid-borne
Flp recombinase (Datsenko and Wanner, 2000).
ACCESSION NUMBERS
Coordinates for the complex of dityromycin with the 70S ribosome have been
deposited in the PDB under accession numbers 4NVU, 4NVV, 4NVW, and
4NVX (dityromycin) and 4NVY, 4NVZ, 4NW0, and 4NW1 (GE82832).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2013.12.024.
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